Karen Basen-Engquist, PhD, MPH
Dr. Karen Basen-Engquist is a Professor of Behavioral Science at The University of Texas MD Anderson Cancer Center. Dr. Basen-Engquist’s research focuses on cancer survivors and the role of health behavior interventions in decreasing the severity of late effects, improving physical functioning, optimizing quality of life, and reducing risk of chronic diseases. In addition, she studies intervention methods for behavior change and innovative real-time methods for assessing symptoms and behavior in cancer patients and survivors. Dr. Basen-Engquist recently completed an R01 study funded by the NCI to investigate the mechanisms of exercise adoption and maintenance in endometrial cancer survivors, using a social cognitive theory model that tests the social, physiological, and behavioral predictors of exercise adherence. Two NCI-funded pilot studies are evaluating the benefits of exercise for advanced colon cancer patients and cancer survivors with chemotherapy induced heart failure. Dr. Basen-Engquist was recently appointed to direct the Center for Energy Balance in Cancer Prevention and Survivorship. Through the center, Dr. Basen-Engquist will endeavor to expand energy balance research at MD Anderson by facilitating collaboration among investigators and expanding infrastructure for research in three broad areas – the effect of exercise, nutrition, and weight control on outcomes in cancer survivors; dissemination and implementation research related to energy balance interventions; and basic biobehavioral mechanisms underlying exercise, eating behavior, and weight loss.
Alice Bender, MS, RDN
Alice Bender translates the science of cancer prevention into practical advice for consumers and healthcare professionals. Through AICR’s Health Professionals program she helps health providers in cancer centers and other settings stay up to date on the research on how diet, weight and physical activity link to cancer prevention and survivorship.
As a spokesperson for AICR, she keeps the public informed on cancer-preventive lifestyle choices through appearances on radio, television and in print and online news sites.
Ms. Bender led the development and implementation of AICR’s recently launched New American Plate Challenge – a web-based 12-week weight-loss program guiding individuals to lower their risk for cancer through healthful eating and moving more.
Prior to joining AICR in 2009, she provided clinical services and health promotion programming at Stanford University and the University of Georgia. She designed and taught a Peer Nutrition Education Course, training dietetics students to provide educational programs on campus.
Alice earned a Master’s Degree in Nutrition and Public Health from Columbia University Teachers College and has been active in leadership in the Academy of Nutrition and Dietetics state and local affiliates.
Marc Bissonnette, MD
Dr. Marc Bissonnette is Associate Professor in the Department of Medicine, Section of Gastroenterology at the University of Chicago. He is member of the University of Chicago Comprehensive Cancer Center and Committee on Molecular Metabolism and Nutrition, as well as Member of the External Advisory Committee for the Human Resource Center at the University of Chicago. Dr. Bissonnette received his BS degree in Physics from Purdue University and his MD from the University of Chicago. After serving three years on active duty in the United States Navy, he completed a residency in Internal Medicine and GI fellowship at the University of Pennsylvania followed by a three-year postdoctoral fellowship at the National Institutes of Health in Digestive Diseases.
Dr. Bissonnette has been affiliated with the University of Chicago since 1990 as a gastroenterologist and colon cancer researcher. His research interests include growth factor signals and diet in colonic carcinogenesis and chemoprevention. He is studying the roles of stroma and epigenetic regulation, including microRNAs in tumorigenesis. Dr. Bissonnette holds a patent on fluorinated vitamin D analogs as colon cancer chemopreventive agents.
Dr. Bissonnette is a member of a number of societies including the American Gastroenterological Society, Midwest Gut Club and the Pancreas Society. He has over 60 publications and carries out reviews for many established journals including Proceedings of the National Academy of Sciences USA, Journal of Biological Chemistry, Oncogene, Cancer Research, Carcinogenesis, Nutrition and Cancer, Neoplasia, Gastroenterology, Journal of Clinical Investigation, American Journal of Physiology-Gastroenterology and American Journal of Physiology-Cell Biology.Back to top
Robert S. Chapkin, PhD
Dr. Robert Chapkin is a member of the Program in Integrative Nutrition & Complex Diseases, and Deputy Director of the NIEHS Center for Translational Environmental Health Research at Texas A&M University. He received his BS in Nutrition and Biochemistry from the University of Guelph, Ontario, Canada; an MS in Nutrition from the University of Guelph, 1983, and a PhD in Nutrition and Physiology Chemistry from the University of California-Davis in 1986. After completing a postdoctoral fellowship in Cancer Biology in the School of Medicine at the University of California-Davis in 1988, he joined the faculty at Texas A&M University. Dr. Chapkin is currently a Regents Professor and University Faculty Fellow and during the past 25 years has published over 210 peer-reviewed articles in nutrition, cancer biology and immunology.
Dr. Chapkin is an expert in dietary chemoprevention of colon cancer and inflammatory bowel diseases. He has made highly significant contributions to cancer chemoprevention in four specific areas: (i) establishment of models for cancer prevention studies, (ii) elucidation of signal transduction processes in the colon, (iii) investigation of the role of inflammation as a critical factor in colon cancer development, and its modulation by diet, and (iv) development of a novel non-invasive Systems Biology-based methodology to monitor diet/host gene/microbiome expression profiles and its application to translational research.Back to top
Steven K. Clinton, MD, PhD
Dr. Steven Clinton is a Professor of Internal Medicine in the Division of Medical Oncology at The Ohio State University. He trained for his MD and PhD at the University of Illinois in Urban-Champaign followed by Internal Medicine internship and residency at the University of Chicago. He proceeded with Medical Oncology training at the Dana-Farber Cancer Institute and Harvard Medical School where he remained on faculty for nearly a decade.
At The Ohio State University he serves as Director of the Prostate and Genitourinary Oncology Program for The James Cancer Hospital. Dr. Clinton also leads the Molecular Carcinogenesis and Chemoprevention Program for the Comprehensive Cancer Center and is co-director of the campus wide Food Innovation Center.
Dr. Clinton’s research activities, described in over 200 publications, include epidemiology, clinical intervention trials, as well as basic laboratory studies of cellular and molecular biology relevant to many aspects of diet, nutrition, and cancer. He provides service to many national organizations including the American Institute for Cancer Research.
He recently served as a member of the CUP Mechanisms Protocol Development Group and continues to have an advisory role to this work. Dr. Clinton recently joined the CUP Panel in November 2012.
Karen Collins, MS, RDN, CDN
Karen Collins is a registered dietitian who promotes healthy eating as a speaker, consultant and writer. Karen serves as Nutrition Advisor to the American Institute for Cancer Research (AICR). She writes a weekly syndicated column, Health Talk, which is carried on websites and in newspapers nationwide. Karen participates in videos and presents seminars for the general public and cancer survivors, and speaks regularly to a variety of health professional audiences. She is also author of the blog, Smart Bytes®.
Based in western New York, Karen conducted a long-time private practice in nutrition counseling, working with individuals and groups to develop realistic strategies for achieving health goals. This work dealt extensively with weight and eating disorder issues, and addressed a wide range of medical problems, such as diabetes and heart health.
A member of the Academy of Nutrition and Dietetics (formerly known as the American Dietetic Association), Karen is Co-Director of the Wellness and Cardiovascular Nutrition subunit of its Sports, Cardiovascular and Wellness Nutrition (SCAN) dietetic practice group. Also a member of the Oncology Nutrition; Diabetes Care and Education; and Nutrition Entrepreneurs dietetic practice groups, Karen holds a BS degree in dietetics from Purdue University and an MS degree in nutrition from Cornell University.
David Crews, PhD
Dr. David Crews is the Ashbel Smith Professor of Psychology and Zoology. He has worked on a wide variety of animals and uncovered the governing principles of how the environment shapes the brain and body. For the last 20 years his work has focused on how the individual develops into a functional addition to the group and how this complex process can be derailed. His recent work has elaborated how an ancestral environmental exposure that produces an epigenetic transgenerational state alters the perception and ability of the animal to respond to stress in regards to subsequent anxiety and affliative behavior in adulthood as well as the metabolic activity, patterns of gene expression, and transcriptional gene networks in specific brain regions. By documenting effects at multiple levels of biological organization, including the physiological, behavioral, neural metabolism, genomics and genetic networks levels, he has been able to illuminate how the causal mechanisms and functional outcomes of related process operate are integrated to “bring the phenotype into being” (Waddington, 1942). He is the recipient of a NIMH Research Scientist Award and a NIMH MERIT Award. He is a Fellow of the American Academy of Arts and Sciences and recipient of the Daniel S. Lehrman Lifetime Achievement Award from the Society for Behavioral Neuroendocrinology.Back to top
Amanda J. Cross, PhD
Dr. Amanda Cross received a BSc in Biology and Biochemistry from the University of Newcastle Upon Tyne, U.K. in 1997 and a PhD in nutrition and cancer from the University of Cambridge, U.K. in 2002. She joined the Division of Cancer Epidemiology and Genetics (DCEG) of NCI as a post-doctoral fellow in 2003 and became a research fellow in 2005 and a tenure-track investigator in 2006. Dr. Cross is principal investigator of the CONCeRN study and of the Polyp Prevention Trial. Her research interests include lower gastrointestinal cancers, developing exposure assessment tools, and etiologic studies of diet and cancer risk. She established and leads a colorectal cancer working group and is a member of the Office of Education Advisory Group and a mentor for the Yale University–NCI Partnership Training Program. In 2010, she received an NCI Mentor of Merit award, as well as an NIH award for Leadership of an Innovative Multidisciplinary Research Program.Back to top
Bess Dawson-Hughes, MD
Dr. Bess Dawson-Hughes graduated from Tufts University School of Medicine, completed her house training at Tufts, and went on to an endocrine fellowship at Harvard Medical School and the Brigham and Women's Hospital. She then received an Individual National Research Service Award at Harvard Medical School. Dr. Dawson-Hughes has served on the councils of several professional organizations, including the American Society for Bone and Mineral Research, the American Society of Clinical Nutrition and the International Bone and Mineral Society. She was an Associate Editor of the Journal of Bone and Mineral Research from 1994 through 2002. Dr. Dawson-Hughes was the Principal Investigator of the NIH Osteoporosis and Related Bone Diseases Resource Center in Washington, DC from 1998-2003, served on the Advisory Council of the National Institute of Arthritis, Musculoskeletal, and Skin Diseases from 2000-2004. She was President of the National Osteoporosis Foundation from 2002-2005 and a member of the Board of Trustees from 1995-2012. She is currently the General Secretariat and a Trustee of the International Osteoporosis Foundation. Dr. Dawson-Hughes has published over 400 peer-reviewed journal articles, book chapters, abstracts, and reviews. Her current research is directed at examining ways in which calcium, vitamin D, protein and other nutrients influence age-related loss of bone and muscle and risk of fragility fractures.Back to top
Wendy Demark-Wahnefried, PhD, RD
Dr. Wendy Demark-Wahnefried is Professor and Webb Endowed Chair of Nutrition Sciences at the University of Alabama at Birmingham (UAB), and also the Associate Director for Cancer Prevention and Control at UAB Comprehensive Cancer Center. Dr. Demark-Wahnefried is a nutrition scientist with training in biochemistry, genetics, and behavioral science. For the past two decades, her research career has spanned basic science studies focused on determining mechanisms of action of food-related components on neoplastic progression, to clinical research that involves nutrition-related concerns of cancer patients, as well as determining effective lifestyle interventions that improve the overall health of cancer survivors and populations at high risk for cancer (relatives of cancer survivors, rural African-Americans residing in high incidence counties, etc). Her laboratory has conducted some of the largest studies exploring metabolic and body composition changes, as well as energy balance, in response to cancer treatment. An area of research in which Dr. Demark-Wahnefried has experienced particular success, is in the delivery of home-based lifestyle interventions among cancer survivors where she has led and continues to lead a number of NIH-funded trials aimed at improving the diet and exercise behavioral of cancer survivors. This work has given rise to over 150 publications, and recognition as a Komen Professor of Survivorship. In addition to her research, Dr. Demark-Wahnefried also serves on several committees, including the American Cancer Society’s Guidelines Panel for Nutrition and Physical Activity among Cancer Survivors, the World Cancer Research Fund, the American College of Sports Medicine Guidelines Panel for Physical Activity in Cancer Survivors, the American Society of Clinical Oncology Committee on Cancer Survivorship, and the National Cancer Policy Forum of the Institute of Medicine (IOM). In October 2011, she chaired the IOM workshop on “The Role of Obesity on Cancer Recurrence and Survival.” She also is the current President-Elect for the American Society of Preventive Oncology.Back to top
Richard L. Eckert, PhD
Dr. Richard Eckert received his bachelor’s degree from the University of Wisconsin, and PhD from the University of Illinois, Urbana. He completed post-doctoral training in the Department of Cell Biology at the Massachusetts Institute of Technology, and in the Department of Physiology and Biophysics at Harvard Medical School.
He joined the faculty of Case Reserve University School of Medicine in 1986 as an Assistant Professor of Physiology and Biophysics, Dermatology, Reproductive Biology, Oncology and Biochemistry. He was promoted as tenured Associate Professor in 1992 and Professor in 1996. Dr. Eckert joined the University of Maryland School of Medicine as Professor and Chair of Biochemistry and Molecular Biology in November of 2006.
Dr. Eckert’s research focuses on understanding how normal surface epithelial cells function to protect people from illnesses and how those cells are altered during disease states, including skin cancer. Specific interests include mechanisms that regulate cell survival, differentiation and transformation, genetic and epigenetic mechanisms that regulate gene expression during differentiation, the use of epidermis-derived somatic stem cells for therapy, and the role of nutritional agents in cancer prevention. He has published more than 160 journal articles and reviews, and his trainees have presented over 130 meeting abstracts. He serves as an editorial board member and reviewer for scientific journals including the Journal of Biological Chemistry and the Journal of Investigative Dermatology. He is a University of Wisconsin Distinguished Alumni Achievement Award recipient, an elected member of the Board of the Society for Investigative Dermatology, a standing member of the review panel of the American Institute for Cancer Research, and has served on the Board of Scientific Counselors of the NIAMS and on numerous NIH study sections.
Dr. Eckert holds two patents from the United States Patent Office, and has been continuously funded by the National Institutes of Health as a principal investigator since 1989. He is currently principal investigator on multiple RO1 grants from the National Institutes of Health and 2 grants from the Maryland Stem Cell Research Fund. He has also been supported by the Department of the Navy, the American Cancer Society, the Dermatology Foundation, and the Congressionally Directed Medical Research Program Breast Cancer Research Program.Back to top
John W. Erdman Jr., PhD
Dr. John Erdman is Emeritus Professor of Food Science and Human Nutrition, Professor of Internal Medicine and Professor of Nutrition in the Division of Nutritional Sciences at the University of Illinois at Urbana. Dr. Erdman's training and expertise encompass the nutritional and physiological biochemistry of man and animals. He has authored over 170 original research articles on these subjects and has over 300 total publications including other articles and chapters. He is a member of a variety of professional organizations including the American Society for Nutrition (ASN), the Institute of Food Technologists (IFT), and the American Heart Association (AHA). He is past President of the American Society for Nutritional Sciences (now ASN), has been elected Fellow for ASN, AHA and IFT. He has been extensively involved with the Food and Nutrition Board (FNB) of the Institute of Medicine, National Academy of Sciences (NAS), where he served on the FNB for 9 years, 6 as Vice Chair. Among other committees of the FNB, he served as Chair of the Standing Committee on the Scientific Evaluation of Dietary Reference Intakes (DRIs) and is was Chair of the Committee on Military Nutrition Research. Recently this committee published the report "Nutrition and Traumatic Brain Injury". For his extensive contributions to the NAS, he was named as Lifetime National Associate of the NAS in 2001 and was elected as a Member of the Institute of Medicine, NAS in 2003. Other honors include: receipt of the Samuel Cate Prescott Award for Research and the William Cruess Award for Teaching from IFT: the Borden Award from ASN; being named as an Original Member in Agricultural Science by ISI as an Highly Cited Researcher (top 0.05%); and several University of Illinois Excellent and Outstanding Teaching awards. He is a member of the Board of Trustees of ILSI- NA. Dr. Erdman has is past Executive Director of the Mars Science Advisory Council and is currently Executive Director of the Wrigley Scientific Advisory Committee. Dr Erdman received his BS, MS, MPH and PhD in Food Science from Rutgers University.Back to top
James C. Fleet, PhD
Dr. James Fleet is a Distinguished Professor in the Department of Nutrition Science and he is the Director of the Interdepartmental Nutrition Program for graduate training in nutrition at Purdue University. He holds a BS and PhD from Cornell University and has previously held faculty appointments at Tufts University and the University of North Carolina at Greensboro. Dr. Fleet's research is focused on the molecular and physiological functions of vitamin D as they pertain to the control of calcium metabolism and the prevention of cancer. He uses the tools of molecular biology, genomics, and genetics to address questions relevant to human health and disease in cell and animal models. He has served as a contributing editor to Nutrition Reviews, on the editorial board of The Journal of Nutrition, and as a member of the INMP and CDP study sections at NIH. He has been an organizer of FASEB Summer Conferences, on the Program Committee for International Workshops on Vitamin D, and he has been an invited to speak on his work across the globe. In 2001, he was the recipient of the Mead Johnson Award from the American Society for Nutrition, in 2004 he was honored as a "University Faculty Scholar" by Purdue University, and in 2012 he was awarded the honor of Distinguished Professor by Purdue University.Back to top
Joel Gittelsohn, MS, PhD
Dr. Joel Gittelsohn is a Professor in the Department of International Health, Johns Hopkins Bloomberg School of Public Health. For the past 22 years, Dr. Gittelsohn has focused his work on developing, implementing and evaluating community-based programs for the primary prevention of chronic disease in disadvantaged ethnic minority populations. Dr. Gittelsohn’s primary work in the past decade has been the development, implementation and evaluation of combined environmental and behavior-change approaches to improve diet and reduce risk for chronic disease. He has led multiple food store-centered intervention trials aimed at improving food availability and providing skills and nutrition education needed to support healthy food choices in Majuro atoll, on three American Indian reservations, in Baltimore City, for Native Hawaiian communities (Novotny PI). Dr. Gittelsohn developed a multi-institutional (food store, school, health services) program for diabetes prevention in First Nations, which is currently being extended to five American Indian communities and will include a worksite component (OPREVENT). These programs have shown success in increasing knowledge, healthy food purchasing and consumption of healthy promoted foods at the consumer level, and maintaining sales at the retail level.Back to top
Karen Glanz, PhD, MPH
Dr. Karen Glanz is George A. Weiss University Professor, Professor of Epidemiology in the Perelman School of Medicine, Professor of Nursing in the School of Nursing, and Director of the Center for Health Behavior Research at the University of Pennsylvania. She is also a Senior Fellow of the Leonard Davis Institute on Health Economics and the Center for Public Health Initiatives and a Distinguished Fellow of the Annenberg Public Policy Center. She was previously at Emory University (2004-2009), the University of Hawaii (1993 to 2004), and Temple University. She received her MPH (1977) and PhD (1979) degrees in health behavior and health education from the University of Michigan.
A globally influential public health scholar whose work spans psychology, epidemiology, and other disciplines, Dr. Glanz has led research funded for over $25 million in the past two decades. Her research in community and health care settings focuses on cancer prevention and control; obesity, nutrition, and the built environment; chronic disease prevention and control; and health communication technologies. She is a member of the US Task Force on Community Preventive Services. Her scholarly contributions consist of more than 350 journal articles and book chapters. Dr. Glanz is senior editor of Health Behavior and Health Education: Theory, Research, and Practice (Jossey-Bass Inc., 1990, 1996, 2002, 2008), a widely used text now in its fourth edition.
Dr. Glanz has been recognized with local and national awards for her work, including being named a Fellow of the Society for Behavioral Medicine, receiving the Elizabeth Fries Health Education Award, and receiving several national awards for her innovative health promotion programs. She was designated a Highly Cited Author by ISIHighlyCited.com, in the top 0.5% of authors in her field over a 20-year period.Back to top
Pamela J. Goodwin MD, MSc, FRCPCDr. Pamela Goodwin has been actively involved in research relating to host factors in breast cancer for the past 25 years. Early in her career, she became intrigued with the possibility that host (patient-related) factors, especially obesity, might impact outcomes of women diagnosed with breast cancer. She began a program of research that has focused on the role of these factors, including obesity, nutrition, exercise and related factors in the clinical course of breast cancer. She has led a number of studies which investigate the complex interactions between body size, nutrition, exercise and physiologic mediators such as insulin, IGF-I and vitamin D, examining the impact of these factors on risk and survival of women diagnosed with breast cancer. Dr. Goodwin has expanded this work to investigate the status of long-term breast cancer survivors and the influences of hereditary factors, vitamin D and metformin on breast cancer outcomes. She currently leads a large international Phase III trial (NCIC MA.32) which examines the impact of an insulin lowering drug, metformin, on breast cancer outcomes and has an active translational research program examining the interface between host factors and tumor biology in both early and advanced breast cancer.
Dr. Goodwin is a Professor of Medicine at the University of Toronto, with cross appointments in the Department of Health Policy, Management and Evaluation and in the School of Graduate Studies. She is a Scientist at the Lunenfeld Tanenbaum Research Institute of Mount Sinai Hospital, Director of the hospital's Marvelle Koffler Breast Centre and holder of the Marvelle Koffler Chair in Breast Research. Dr. Goodwin has published over 150 research articles in leading journals. She is also active in the clinical management of breast cancer patients.
Marc E. G. Hendrickx, PhD
Dr. Marc Hendrickx is senior professor in food technology at Katholieke Universiteit Leuven. He is chairman of the Centre for Food and Microbial Technology, head of the Laboratory of Food Technology (LFT), member of the board of LFoRCe (the Leuven Food and Nutrition Research Center) and co-director of the InterUniversity Program in Food Technology (IUPFOOD). Dr. Hendrickx has been involved in 13 multipartner EU funded projects (in the fields of thermal processing, high pressure processing and pulsed electric field processing), of which 6 as a coordinator. Currently he is a key scientist and member of the management board of High Tech Europe and HST-Food-Train. He is co-author of 320 papers in peer review journals and over 300 contributions to international conferences and workshops.
His research activities focus on the effect of food processing and preservation technologies on food functional properties. Technologies refer to structure enabling and preservation technologies including conventional technologies (thermal processing, freezing and frozen storage) and new technologies (high pressure thermal processing, high pressure freezing and high pressure homogenization). Functional properties include food structural aspects and the retention, generation and in vitro accessibility of health related compounds. The research approach focuses on kinetic and mechanistic aspects and scientific approaches for quantitative process impact evaluation. This includes the development of extrinsic indicator systems and the identification of intrinsic indicator systems based on profiling and targeted component analysis.Back to top
Stephen D. Hursting, PhD, MPH
Dr. Stephen Hursting is Professor and Chair of the Department of Nutritional Sciences at the University of Texas at Austin. He is also the McKean-Love Chair of Nutrition, Molecular and Cellular Sciences at the University of Texas and is Professor of Molecular Carcinogenesis at the UT-MD Anderson Cancer Center. Dr. Hursting earned his PhD in nutritional biochemistry and MPH in nutritional epidemiology from the University of North Carolina, and he completed postdoctoral training in molecular carcinogenesis and cancer prevention at the NCI. Prior to joining the University of Texas in 2005, Dr. Hursting was Deputy Director of the NCI’s Office of Preventive Oncology and Chief of the NCI’s Nutrition and Molecular Carcinogenesis Laboratory Section. His research, which has resulted in over 150 publications, centers on diet-gene interactions relevant to cancer prevention, particularly the molecular, metabolic and inflammatory mechanisms underlying obesity-cancer associations.Back to top
Elizabeth Jeffery, PhD
Dr. Elizabeth Jeffery joined the University of Illinois in 1983, where she is Professor Emerita in the Department of Food Science and Human Nutrition, as well as the College of Medicine and the Interdisciplinary Division of Nutritional Sciences. Dr. Jeffery performs research in the area of diet and disease prevention, and has served as program director for a multi-State research program on bioactive food components. She is particularly interested in how to enhance the health benefits provided by the whole foods that we eat, such as frozen broccoli, microwave heated. She has over a hundred peer-reviewed publications, including a chapter on bioactive food components in the major textbook on nutrition for graduate schools, “Biochemical, Physiological, Molecular Aspects of Human Nutrition.” She has served on committees for the National Academy of Science, focused on safety and efficacy of dietary supplements and on numerous USDA, NIH, Army and DOD study sections, in the areas of Pharmacology, Toxicology, Nutrition and Disease Prevention. Dr. Jeffery has her BSc and PhD in Biochemistry from the University of London, England.Back to top
Sharon Kirkpatrick PhD, MHSc
Dr. Sharon Kirkpatrick is an Assistant Professor in the School of Public Health and Health Systems at the University of Waterloo in Ontario, Canada. She was previously a visiting fellow at the U.S. National Cancer Institute. Her research focuses on disparities in diet in relation to income and race/ethnicity. She also works in dietary assessment and the analysis of dietary intake data to account for measurement error, as well as the measurement of food environments. Dr. Kirkpatrick recently organized a 12-part webinar series that drew hundreds of participants from several countries and aimed to disseminate advances in reducing and addressing measurement error in dietary data. Other research interests include food policy and dietary guidance. Dr. Kirkpatrick earned her PhD in Nutritional Sciences and MHSc in Community Nutrition from the University of Toronto.Back to top
M. Tish Knobf, PhD, FAAN, AOCN
Dr. M. Tish Knobf is Professor at the Yale University School of Nursing, Fellow in the American Academy of Nursing and a member of Yale Cancer Center. Dr Knobf’s clinical practice and program of research involving women with breast cancer has spanned the last three decades. Her research began with a seminal paper in 1983 describing the phenomena of weight gain in women with breast cancer on adjuvant therapy. Her program of research has addressed the acute, long term and late effects of therapy as adjuvant therapies have evolved, including physical and psychological symptom distress, informational needs and quality of life outcomes. Dr. Knobf’s current research targets the transition from treatment to survivorship for women. She recently completed a community based psycho-educational program focused on healthy eating and physical activity for women of color cancer survivors supported by the Lance Armstrong Foundation. Her ongoing intervention study is a National Cancer Institute funded 12 month randomized controlled trial of aerobic-resistance exercise compared to a home based physical activity group to assess the effect on bone mass, body composition, metabolic risk factors and cardiovascular fitness. A companion pilot study to the RCT is exploring the association of biomarkers of inflammation to bone, body composition, metabolic and cardiac outcomes of the exercise intervention.Back to top
Johanna Lampe, PhD, RD
Dr. Johanna Lampe is a Full Member and Associate Division Director in the Public Health Sciences Division at Fred Hutchinson Cancer Research Center and a Research Professor in the Department of Epidemiology at the University of Washington in Seattle. She received her PhD in nutritional sciences, with a minor in biochemistry, from the University of Minnesota and trained as a post-doctoral fellow in epidemiology at the University of Minnesota before joining the faculty at Fred Hutchinson Cancer Research Center in 1994. Dr. Lampe’s research focuses on the effect of diet constituents on cancer susceptibility in humans and the effects of genetic variation on response to diet. Her group uses controlled dietary interventions to evaluate cancer biomarker-response to diet and specific phytochemicals. In addition, her lab studies the modifying effects of the gut microbiome on phytochemical metabolism and disease risk. One of her current research projects, supported by the NIH and in collaboration with Drs Chapkin (TAMU) and Hullar (FHCRC), addresses the effects of bacterially-derived enterolignans on gut epithelial and stromal gene expression. Dr. Lampe is a member of the American Association for Cancer Research, the Academy of Nutrition and Dietetics, the American Society for Nutrition, and the Groupe Polyphénols. She is an elected member of the AACR Molecular Epidemiology Working Group Steering Committee.
Chiang J. Li, MD FACP
Dr. Li is an accomplished clinician, scientist, inventor, and entrepreneur. He serves as Director of the Skip Ackerman Center for Molecular Therapeutics, Department of Medicine/Gastroenterology, Beth Israel Deaconess Medical Center/Harvard Medical School, and President/CEO/Chief Medical Officer at Boston Biomedical. Dr. Li also serves as Head of Global Oncology for Dainippon Sumitomo Pharma Group.
Dr. Li is the named inventor in over 230 patents and patent applications, and has translated a number of his laboratory inventions to patients for the treatment of cancer. Examples include: 1) BBI608, a first-in-class cancer stem cell inhibitor, in Phase III initiation, which has been selected as one of the 2012 Global Top Ten Promising Late Stage Cancer Drugs. 2) BBI503, a first-in-class cancer stemness kinase inhibitor, in clinical trials; 3) Tivantinib (ARQ197), a first-in-class c-Met inhibitor with a class-leading profile and clinical activity against lung cancer and liver cancer, in global Phase III trials; 4) TransKingdom Gene Silencing, a bacteria-based gene silencing technology, currently in trials (the first oral gene silencing clinical trial to be cleared by FDA); and 5) aiRNA Technology, the sole recipient in healthcare in 2010 of the North American Technology Innovation of the Year Award. aiRNA technology is considered a potential game-changing innovation by world-leading experts in multiple commentary articles. Dr. Li and his work have also received a number of other recognitions, including Directly Elected Fellow (American College of Physicians); America’s Top Physician (Consumer Research Council); GRL Biotechnology Award (Korean Ministry of Science and Technology); Biotech Pioneer (Alexandria Oncology Summit); Innovator of the Year (2012, Chinese American Biomedical Association); and 2012 Honoree of Massachusetts Asian American Commission.
Dr. Li graduated from the Harvard-MIT Division of Health Science and Technology, received his M.D. magna cum laude from Harvard Medical School, completed his residency and fellowship training at Brigham & Women’s Hospital/Dana-Farber Cancer Institute and Beth Israel Deaconess Medical Center, and conducted postdoctoral research under Prof. Arthur B. Pardee at Harvard Medical School. Dr. Li’s laboratory has published numerous highly cited articles in top leading journals.Back to top
Jennifer Ligibel, MD
Dr. Jennifer Ligibel is a medical oncologist in the Women’s Cancer Program at Dana-Farber Cancer Institute and Assistant Professor at Harvard Medical School. Her research focuses on the study of energy balance and breast and other cancers. Dr. Ligibel has conducted several studies looking at the impact of increased physical activity upon serum biomarkers, anthropometric measures and psychosocial outcomes in breast cancer survivors and patients undergoing adjuvant therapy. Other recent work has focused on the relationship between obesity and outcomes in women with early breast cancer treated on adjuvant chemotherapy protocols. Dr. Ligibel has also studied distance-based lifestyle interventions and has recently published a study looking at the feasibility of a telephone-based physical activity intervention conducted in a cooperative group setting and is currently directing a weight-loss intervention as part of a multicenter trial looking at the impact of novel treatment approaches in women with residual breast cancer after neoadjuvant chemotherapy. Dr. Ligibel is also a part of the National Cancer Institute Transdisciplinary Research in Energetics and Cancer initiative and co-directs a project looking at the impact of exercise and metformin on metabolic and inflammatory biomarkers in colorectal cancer survivors. She is also conducting a trial looking at the impact of exercise on proliferation and other tissue-based biomarkers in women with newly diagnosed breast cancer. Finally, she is an active member of the Alliance for Clinical Trials in Oncology, where her work focuses on lifestyle intervention studies in breast cancer survivors.Back to top
Karen A. Lillycrop, PhD
Dr. Karen Lillycrop is a Reader in Developmental Epigenetics at the Institute of Developmental Sciences at the University of Southampton. Dr. Lillycrop obtained her first degree in Chemistry and Biochemistry at Imperial College, London followed by her doctorate in Biochemistry at the University of Leicester. Dr. Lillycrop then undertook post-doctoral research at University College London in Professor David Latchman’s laboratory where she studied gene regulation and the role of transcription factors in disease. In 1995 Dr. Lillycrop moved to Southampton to take up a lectureship in Molecular Biology at the University of Southampton. Dr. Lillycrop’s current research is focused on how early life environment influences the epigenetic regulation of genes and the development of human disease and was the first to demonstrate that maternal diet can alter the epigenetic regulation of key transcription factors within the fetus. Dr. Lillycrop has been awarded a number of research prizes including the Nick Hales Award 2007 for outstanding contribution into the Developmental origins of Health and Disease. She collaborates extensively with research groups within Southampton University including Professor Alan Jackson and Dr. Graham Burdge (Institute of Human Nutrition) and Professor Mark Hanson (Developmental Origins of Health and Disease) as well as with groups in the Netherlands, Singapore and Auckland. The group is funded by project grants from BBSRC and EU and is part of the Epigen Research Consortium.Back to top
John A. Milner, PhD
Dr. John Milner is currently the Director and Senior Scientist at the USDA Beltsville Human Nutrition Center. From 2000 to 2012, he was Chief of the Nutritional Science Research Group in the Division of Cancer Prevention at the National Cancer Institute. From 1989 to 2000, he was Head of and a Professor in the Department of Nutrition at The Pennsylvania State University where he also served as Director of the Graduate Program in Nutrition. Before joining Penn State, he was a faculty member for 13 years in the Food Science Department at the University of Illinois-Urbana-Champaign. While at the University of Illinois, he served as the Director of the Division of Nutritional Sciences and as an Assistant Director of the Agricultural Experiment Station. He is a fellow in the American Association for the Advancement of Science, a fellow of the Institute of Food Technologists, and an Honorary Member of the American Dietetic Association.
Dr. Milner has served in an advisory capacity as a member of the U.S. Department of Agriculture’s Human Nutrition Board of Scientific Counselors, Joint USDA/HHS Dietary Guidelines Committee, and for the Food, Nutrition and Safety Committee within the International Life Sciences Institute (ILSI). Dr. Milner has served as president of the American Society for Nutrition (formerly the American Institute of Nutrition) and has testified before the Subcommittee on Appropriations in Washington, D.C. and the Presidential Commission on Dietary Supplement Labels in Baltimore, Maryland. He has served as a member of the National Academy of Sciences Committee on Military Nutrition Research, the U.S. Olympic Committee Dietary Guidelines Task Force, the External Advisory Board for the Pennington Biomedical Research Center, as a member and Vice-Chair for the Counsel of Experts of United States Pharmacopeia Committee on Bioavailability and Nutrient Absorption, a member of the External Advisory Board for the European Commission SeaFood Plus initiative and as the chair of the World Cancer Research Fund/American Institute for Cancer Research Mechanisms Working Group. He is currently a member of the Global Board of Trustees for ILSI, liaison to the International Food Information Council (IFIC), member of the Danone Institute’s International Functional Foods and Health Claims Knowledge Center Committee, a member of the Board for the McCormick Science Institute and a member of the Mushroom Research Board. In his current position, he promotes research that deals with the physiological importance of dietary bioactive compounds as modifiers of cancer risk and tumor behavior.Back to top
Joseph H. Nadeau, PhD
Dr. Joseph Nadeau is an internationally-recognized expert in genetic, genomic, metabolic, bioinformatics, computational and systems studies of mouse models of birth defects, cancer and metabolic disease as well as translating results to these studies in humans. He has been a pioneer in comparative genomics (comparative gene mapping), genetics and systems studies of mouse models of human disease (chromosome substitution strains) as well as transgenerational epigenetic effects on cancer, metabolism, embryogenesis and behavior based on discoveries that change the ways that we understand inheritance of phenotypic variation and disease susceptibility.
He is formerly James H. Jewel Professor and Chair of Genetics Department at Case Western Reserve University School of Medicine. He was a founding member of the International Mammalian Genome Society and a founding editor of both Mammalian Genome and WIRES Systems Biology and Medicine; the latter won the RR Hawkins Award from the American Publishers Awards for Professional & Scholarly Excellence (PROSE) — this is the top award for outstanding scholarly work in all disciplines of the arts and sciences. He was founder and director of the Mouse Genome Informatics Project and the Mouse Genome Database. He has served on numerous review panels and advisory groups at the National Institutes of Health, the National Science Foundation, the Wellcome Trust, and the Human Genome Database; he has also consulted for several biotech and major pharmaceutical companies. His work has received several awards and he is an Elected Fellow of the American Association for the Advancement of Science. His work was recently recognized with an NIH Pioneer Award. Finally, his students and fellows have won numerous local, national and international awards for their work.Back to top
Sherry Pagoto, PhD
Dr. Sherry Pagoto is an Associate Professor of Medicine at the University of Massachusetts Medical School. She has a clinical post at the University of Massachusetts Medical Center Weight Center. Dr. Pagoto received a doctoral degree in clinical psychology in 2001 from Western Michigan University. In 2006, she was recipient of the Society of Behavioral Medicine (SBM) Early Investigator Award and in 2011 she received the Western Michigan University Department of Psychology Alumni Award.
She has had a federally funded program of research for 10 years and has 90 peer-reviewed publications. Her research focuses on two areas relevant to cancer: the treatment of obesity and skin cancer prevention. Her obesity research targets adults with psychological comorbidities, including depression. Her projects also leverage mobile technologies and online social networks to improve adherence to lifestyle changes. Her skin cancer prevention research has focused on interventions to reduce tanning in the sun as well as via artificial UV devices. In a current project funded by the CDC, she is exploring tanning behavior and safety practices among young adults who engage in indoor tanning at locations other than tanning salons (e.g., gym, home tanning beds, apartment/dorms).
Dr. Pagoto is on the Board of Directors of SBM and Chair of the SBM Public Policy Leadership Group. She is also active on social media. She blogs for Psychology Today and is a frequent guest blogger for KevinMD.com.Back to top
Elizabeth A. Platz, ScD, MPH
Dr. Elizabeth Platz is a Professor in the Department of Epidemiology at the Johns Hopkins Bloomberg School of Public Health, and the Department of Urology and the James Buchanan Brady Urological Institute at the Johns Hopkins School of Medicine, and the Leader of the Cancer Prevention and Control Program at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. Her research on prostate and colon cancers sits at the interface between epidemiology and basic science. Within prospective cohorts, she studies the association of genetic and epigenetic factors as well as circulating markers of androgenicity, inflammation, and oxidation with prostate cancer incidence and recurrence. For colorectal neoplasia, her work focuses on the metabolic syndrome, growth factors, and inflammation as sequelae of adiposity. She also studies the role of modifiable factors that influence these pathways, such as diet and lifestyle, in relation to the incidence of these diseases and other men’s health concerns. In addition, she studies these factors in association with benign conditions of the prostate and colon, including benign prostatic hyperplasia and adenomatous polyps. She has a long-standing interest uncovering explanations for the notably higher rate of prostate cancer in African-American men compared to white men, including racial variation in sex steroid hormones in the in utero milieu and throughout life. Dr. Platz conducts her multidisciplinary work with an eye toward translation; that is, identifying strategies to prevent the development or progression of cancer. These goals have led to her recent research interest in the possible benefits of drugs for other indications as well as their underlying mechanisms of action in the prevention of the development and recurrence of prostate cancer. Finally, she dabbles in research that identifies and solves methodologic issues in study design germane to epidemiologic and translational studies on prostate cancer detection, incidence, prognosis, and recurrence.
Kim Robien, PhD, RD, CSO, FAND
Dr. Robien is a registered dietitian, nutritional scientist, and epidemiologist whose research focuses on nutrition in relation to cancer prevention and survivorship. She is also interested in environmental nutrition and sustainable food systems, and the extent to which food and water-borne environmental contaminants (such as plasticizers from food processing/storage) may contribute to the risk of obesity, cancer and other chronic diseases.
Dr. Robien is an active member of the American Association for Cancer Research, the American Society for Clinical Oncology, the American Public Health Association and the Academy of Nutrition and Dietetics. She is also a member of the Editorial Boards of the Journal of the Academy of Nutrition and Dietetics and Nutrition in Clinical Practice.
Cheryl Rock, PhD, RD
Dr. Cheryl Rock is a professor in the Department of Family and Preventive Medicine, and the Cancer Prevention and Control Program, University of California, San Diego, School of Medicine. She completed undergraduate training in nutrition and dietetics at Michigan State University, achieved a Master of Medical Science degree in clinical nutrition at Emory University, and was awarded a doctoral degree in nutritional sciences from the University of California, Los Angeles.
Dr. Rock’s research efforts are focused on the role of nutritional and dietary factors in the development and progression of cancer, particularly breast cancer, and healthy weight management in adults. Her research efforts address diet composition and weight management, and how diet, adiposity and physical activity affect biomarkers and risk and progression of cancer and other chronic diseases. Dr. Rock is presently responsible for randomized trials funded by the National Institutes of Health (NIH) that are testing whether healthy weight control and modifications in diet and physical activity can alter biological processes, hormonal factors, and biomarkers of disease progression. She also serves as a co-investigator on several NIH-funded studies that are focused on obesity, various weight loss interventions, and behavioral and metabolic factors associated with disease risk. Dr. Rock leads the Nutrition Shared Resource of the Moores UCSD Comprehensive Cancer Center, a laboratory and dietary assessment recharge service unit that is focused on identifying and measuring dietary biomarkers and improving dietary assessment methods.
Dr. Rock has served on numerous NIH and USDA review panels and committees, and she currently serves on editorial boards for several peer-reviewed journals. To date, Dr Rock is the author of more than 235 scientific papers and book chapters.
Sharon A. Ross, PhD, MPH
Dr. Sharon Ross is a Program Director in the Nutritional Science Research Group, Division of Cancer Prevention, National Cancer Institute, National Institutes of Health. In this capacity, she is responsible for directing, coordinating and managing a multi-disciplinary research grant portfolio in diet, nutrition, and cancer prevention. Topics in her portfolio and research interests include: molecular approaches to diet and pancreatic cancer; diet, epigenetic events, and cancer prevention; nutrition and nanotechnology; as well as diet, obesity and cancer risk. Dr. Ross has a PhD in Nutritional Sciences from the University of Maryland, College Park and a Masters of Public Health from Johns Hopkins University School of Public Health with an emphasis in Epidemiology. Prior to joining the NCI, Dr. Ross worked at the Center for Food Safety and Applied Nutrition, Food and Drug Administration (FDA). At FDA, she was involved in scientific review and regulation development for health claim labeling. Before FDA, Dr. Ross was a Cancer Prevention Fellow in the Division of Cancer Prevention and Control, NCI. Sharon did her doctoral dissertation research in the Laboratory of Cellular Carcinogenesis and Tumor Promotion at NCI where her research topic concerned the effects of retinoids in growth, differentiation, and cell adhesion. Dr. Ross also holds a MS in Nutritional Sciences from the University of Connecticut and a BS in Nutrition and Dietetics from the University of New Hampshire.Back to top
Fazlul H. Sarkar, PhD
Dr. Fazlul Sarkar is currently a Distinguished Professor, Departments of Pathology and Oncology at Karmanos Cancer Institute, Wayne State University School of Medicine. Dr. Sarkar’s early research, which still continues, is focused on understanding the role of a “master” transcription factor, NF-kB, and the regulation of its upstream and downstream signaling molecules in solid tumors, and focusing on tumor microenvironment. Moreover, his research has been directed toward elucidating the molecular mechanism(s) of action of “natural agents,” their synthetic analogues, and other synthetic small molecule inhibitors of Bcl-2 and MDM2 for cancer prevention and therapy. The discoveries from in vitro and in vivo preclinical studies led to the design and execution of multiple Phase I/II clinical trials in breast, pancreas and prostate cancer for assessing the effects of several “natural agents” in the alterations of biomarkers as well as some early clinical efficacy testing. Dr. Sarkar’s research led to the concept of chemo-sensitization of cancer cells by reversing their drug-resistance phenotype to conventional therapeutics (chemo-radio-therapy), and all of which has been focused on tumor microenvironment, which led to clinical trials conducted at the Karmanos Cancer Institute. The innovation of his basic science research has attracted clinicians to collaborate with him, which clearly documents his leadership in translational research. Dr. Sarkar’s collaborations with basic scientists and physician scientists at MD Anderson Cancer Center led him to become a project leader for the Pancreas Cancer SPORE grant of MD Anderson Cancer Center under the leadership of Dr. James Abbruzzese, and Dr. Sarkar also served as a co-investigator for the University of Michigan Head and Neck Cancer SPORE grant.Back to top
June Stevens, MS, PhD
Dr. June Stevens is Chair of the Department of Nutrition at the University of North Carolina at Chapel Hill and the American Institute for Cancer Research Distinguished Professor. Dr. Stevens is an obesity epidemiologist with a large research program focusing on the causes, consequences, and prevention of obesity in different populations. She has served as Principal Investigator of the Coordinating Center for three NIH-funded multi-center trials: Pathways, Trial of Activity in Adolescent Girls (TAAG) and the Childhood Obesity Prevention and Treatment Research Consortium (COPTR). Areas of recent focus include methodology to assess the home food environment using bar code scanning and studies of the impact of food in the home on diet and obesity. Other recent work examines associations between obesity, weight change and cancer incidence and recurrence and characterization of the “healthy obese”. Dr. Stevens has served as an obesity expert for the National Institutes of Health, the Centers for Disease Control, the Institute of Medicine and the World Health Organization.Back to top
Henry J. Thompson, PhD
Dr. Henry Thompson is professor in the College of Agricultural Sciences and director of the Cancer Prevention Laboratory at Colorado State University in Fort Collins, Colorado. Dr. Thompson is a member of the American Association for Cancer Research and the American Society for Nutritional Sciences. Dr Thompson has published more than 165 journal articles and book chapters. Dr. Thompson has a long standing interest in the prevention of, and prognosis in, breast cancer and he maintains an active program of clinical and laboratory research that addresses this topic.
Since 1988, Dr. Thompson’s laboratory has been investigating the mechanisms underlying the cancer inhibitory activity of energy restriction and exercise. The focus of these studies using preclinical models has been on identifying the cellular processes, molecular machinery, and chemical mediators by which these interventions regulate tissue size homeostasis and inhibit the carcinogenic process. Currently, his laboratory is investigating the effects of energy restriction mimetic agents such as 2-deoxyglucose and metformin on cancer initiated cell deletion from the breast. Since 1993, Dr. Thompson has been working with a team of medical oncologists specializing in breast cancer in order to translate his preclinical findings into effective clinical weight control interventions.Back to top
Ari VanderWalde, MD, MPH, MBioeth
Dr. Ari VanderWalde is a Medical Oncologist and Senior Medical Scientist in Global Development of Oncology Therapeutics at Amgen in Thousand Oaks, California. Dr. VanderWalde completed his undergraduate training in Biology at Harvard University, received his Medical Degree and a Masters in Biomedical Ethics from the University of Pennsylvania, and subsequently returned to Harvard to obtain a Masters in Public Health. He completed his internal medicine training at the University of California, Los Angeles, and his hematology-oncology training at City of Hope National Medical Center in Duarte, CA. Dr. VanderWalde is an expert in the design and conduct of clinical trials in cancer, and has performed studies in a wide variety of malignancies (including breast and head and neck cancers, leukemia and lymphoma, and melanoma). Prior to pursuing a career in oncology drug development, Dr. VanderWalde focused his research on geriatric oncology and cancer survivorship, and studied under Dr. Arti Hurria and Dr. Smita Bhatia at City of Hope. Dr. VanderWalde is the author of numerous peer-reviewed publications on cancer survivorship, cancer in older adults, and clinical and research ethics, as well as publications and abstracts of various clinical trials.Back to top
Dianne S. Ward, EdD
As a Professor of Nutrition in the Gillings School of Global Public Health, Dr. Dianne Ward’s research focuses on preventing childhood obesity through home, school, and community interventions that promote healthy eating and regular physical activity in children and families. Recent NIH-funded projects include Parenting SOS, an intervention directed at changing parenting behaviors in support of the development of healthy child weight and HomeSTEAD – a project to develop an assessment of the home food and physical activity environments. With funding from the Robert Wood Johnson Foundation, Dr. Ward led the development of a new self-report instrument (EPAO-SR) for the assessment of nutrition and physical activity environments at child care settings. Dr. Ward led the team that developed a policy and environmental intervention for child care, NAP SACC – The Nutrition and Physical Activity Self-Assessment for Child Care. NAP SACC is a highly regarded program within the public health community, and is used in many states and communities. Based on NAP SACC’s success, she is currently involved in the First Lady’s Let’s Move! Child Care initiative to promote healthy weight development at child care settings. She recently received funding from NIH for a 5-year intervention study to prevent obesity in young children in family home child care settings. Healthy You, Healthy Home, Healthy Business will focus on improving providers’ personal health as well promoting a healthy home using strategies developed in the NAP SACC and HomeSTEAD projects.Back to top
Robert A. Waterland, PhD
Dr. Robert Waterland is an Associate Professor at Baylor College of Medicine, and is based in the USDA/ARS Children’s Nutrition Research Center in Houston, Texas. He holds faculty appointments in the Department of Pediatrics / Nutrition and the Department of Molecular & Human Genetics.
Dr. Waterland received his BS in Physics from Virginia Polytechnic Institute and State University, and worked for several years at the University of Pennsylvania, first with Britton Chance (biochemistry/biophysics), then with Albert Stunkard (clinical obesity research). After earning his PhD in Human Nutrition from Cornell University (with Cutberto Garza), he conducted postdoctoral research in developmental genetics with Randy Jirtle at Duke University.
Dr. Waterland’s research focuses on understanding how nutrition during critical periods of prenatal and early postnatal development affects gene expression, metabolism, and chronic disease susceptibility in adulthood. His laboratory studies both mouse models and humans to elucidate the mechanisms by which early nutrition and other environmental influences affect the establishment and maintenance of epigenetic mechanisms. He is a member of the American Society for Nutrition and the American Society of Human Genetics, and serves on the council of the International Society for Developmental Origins of Health and Disease and the board of directors of the Epigenetics Society.Back to top
Kathleen Y. Wolin, ScD, FACSM
Dr. Kate Wolin is a behavioral epidemiologist whose research focuses on the role of lifestyle in cancer prevention and control. She is an Associate Professor of Public Health Sciences and Surgery at Loyola University Chicago's Stritch School of Medicine. Her current research investigates the role of physical activity and obesity in cancer etiology among high-risk individuals and in cancer treatment sequelae. While at Washington University in St. Louis, Dr. Wolin was the PI of a study of bone health outcomes among breast cancer survivors engaging in weight loss, the PI of an observational study of energy balance and post-prostatectomy urinary and sexual function and the site PI of a vanguard trial of weight loss and quality of life and disease free survival in breast cancer. She also researches the implementation of cancer prevention and control knowledge in cancer survivorship care.
Dr. Wolin blogs at drkatewolin.com and can be found on Twitter @drkatewolin. Dr. Wolin has a BA in anthropology from Tufts University and a ScD in epidemiology from the Harvard School of Public Health where she was an NCI-funded Cancer Prevention and Epidemiology fellow. She completed her postdoctoral training as an NCI-funded fellow in cancer epidemiology at Northwestern University. Dr. Wolin is a fellow in the American College of Sports Medicine.Back to top
Published on October 17, 2013